218 related articles for article (PubMed ID: 16426085)
1. Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial.
Connor KM; Cook JL; Davidson JR
J Clin Psychiatry; 2006 Jan; 67(1):30-6. PubMed ID: 16426085
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR; Gelenberg AJ; Munjack D
Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
[TBL] [Abstract][Full Text] [Related]
3. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
Rummaneethorn P; Chalermchai T
Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.
Book SW; Thomas SE; Randall PK; Randall CL
J Anxiety Disord; 2008; 22(2):310-8. PubMed ID: 17448631
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
Naumann M; Lowe NJ
BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
Liebowitz MR; Stein MB; Tancer M; Carpenter D; Oakes R; Pitts CD
J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.
Wagner KD; Berard R; Stein MB; Wetherhold E; Carpenter DJ; Perera P; Gee M; Davy K; Machin A
Arch Gen Psychiatry; 2004 Nov; 61(11):1153-62. PubMed ID: 15520363
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.
Stein MB; Liebowitz MR; Lydiard RB; Pitts CD; Bushnell W; Gergel I
JAMA; 1998 Aug; 280(8):708-13. PubMed ID: 9728642
[TBL] [Abstract][Full Text] [Related]
9. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP
J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
[TBL] [Abstract][Full Text] [Related]
11. A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.
Stein DJ; Berk M; Els C; Emsley RA; Gittelson L; Wilson D; Oakes R; Hunter B
S Afr Med J; 1999 Apr; 89(4):402-6. PubMed ID: 10341825
[TBL] [Abstract][Full Text] [Related]
12. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
Stein MB; Fyer AJ; Davidson JR; Pollack MH; Wiita B
Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with paroxetine in social anxiety disorder.
Baldwin DS
Int Clin Psychopharmacol; 2000 Jul; 15 Suppl 1():S19-24. PubMed ID: 10994679
[TBL] [Abstract][Full Text] [Related]
14. Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.
Stein MB; Sareen J; Hami S; Chao J
Am J Psychiatry; 2001 Oct; 158(10):1725-7. PubMed ID: 11579011
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.
Rickels K; Zaninelli R; McCafferty J; Bellew K; Iyengar M; Sheehan D
Am J Psychiatry; 2003 Apr; 160(4):749-56. PubMed ID: 12668365
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
Schnider P; Binder M; Kittler H; Birner P; Starkel D; Wolff K; Auff E
Br J Dermatol; 1999 Apr; 140(4):677-80. PubMed ID: 10233320
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
Heckmann M; Ceballos-Baumann AO; Plewig G;
N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
[TBL] [Abstract][Full Text] [Related]
19. [Treated patients in survey: High satisfaction with botulinum toxin in palmar hyperhidrosis].
Deebaj R; Emtestam L; Lundeberg L; Brandin Samuelsson K; Girnita A
Lakartidningen; 2015 Jan; 112():. PubMed ID: 25625725
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine in social phobia.
Mancini C; Ameringen MV
J Clin Psychiatry; 1996 Nov; 57(11):519-22. PubMed ID: 8968300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]